Hilary S Connery
Overview
Explore the profile of Hilary S Connery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mather R, Jack H, Warren K, Comrie C, Li S, Liu M, et al.
Acad Med
. 2025 Mar;
PMID: 40048728
Problem: The opioid overdose crisis had progressed broadly in the United States, with an 21% increase from 2016 to 2017, and specifically in Massachusetts, with a peak rate of 1,374...
2.
Dernbach M, Seery E, Rasimas J, Connery H
Clin Toxicol (Phila)
. 2025 Jan;
63(2):75-82.
PMID: 39868623
Background: Overdose is frequently categorized dichotomously: an inadvertent therapeutic or recreational misadventure versus a deliberate overdose for self-injurious or suicidal purposes. Categorizing overdoses based on this dichotomy of intention is...
3.
Straub L, Bateman B, Hernandez-Diaz S, Zhu Y, Suarez E, Vine S, et al.
JAMA
. 2024 Aug;
332(10):805-816.
PMID: 39133511
Importance: Buprenorphine combined with naloxone is commonly used to treat opioid use disorders outside of pregnancy. In pregnancy, buprenorphine alone is generally recommended because of limited perinatal safety data on...
4.
Drozek R, Bateman A, Henry J, Connery H, Smith G, Tester R
Int J Group Psychother
. 2024 Mar;
71(3):441-470.
PMID: 38449226
Law enforcement violence has emerged as a leading public health concern, and law enforcement officers are themselves at greater risk for a range of psychiatric disorders. Drawing on the significant...
5.
Saberi S, Moore S, Li S, Mather R, Daniels M, Shahani A, et al.
BMC Med Educ
. 2024 Mar;
24(1):241.
PMID: 38448949
Background: Naloxone is an effective and safe opioid reversal medication now approved by the U.S. Food and Drug Administration (FDA) for use with or without a prescription. Despite this, naloxone...
6.
Suarez E, Bateman B, Straub L, Hernandez-Diaz S, Jones H, Gray K, et al.
JAMA Intern Med
. 2024 Jan;
184(3):242-251.
PMID: 38252426
Importance: Use of buprenorphine or methadone to treat opioid use disorder is recommended in pregnancy; however, their teratogenic potential is largely unknown. Objective: To compare the risk of congenital malformations...
7.
Barenie R, Bateman B, Connery H, Tsacogianis T, Kesselheim A
J Subst Use Addict Treat
. 2023 Dec;
159:209243.
PMID: 38052268
Introduction: Clinical practice guidelines recommend drug testing patients who are receiving opioids chronically for pain or medication for a substance use disorder (SUD)-particularly opioid use disorder (OUD)-but practices vary due...
8.
Connery H, Weiss R
Am J Psychiatry
. 2023 May;
180(5):337-339.
PMID: 37122270
No abstract available.
9.
Suarez E, Huybrechts K, Straub L, Hernandez-Diaz S, Creanga A, Connery H, et al.
Obstet Gynecol
. 2023 Mar;
141(4):657-665.
PMID: 36897177
Objective: To assess the incidence and risk factors for postpartum opioid overdose death and describe other causes of postpartum death in individuals with opioid use disorder (OUD). Methods: We conducted...
10.
Rockett I, Ali B, Caine E, Shepard D, Banerjee A, Nolte K, et al.
BMC Public Health
. 2023 Feb;
23(1):285.
PMID: 36755229
Background: Estimating the economic costs of self-injury mortality (SIM) can inform health planning and clinical and public health interventions, serve as a basis for their evaluation, and provide the foundation...